Lipid-Based Nanocarriers for Targeted Drug and Nutraceutical Delivery: Development, Characterization, Applications, and Industrial Challenges
Abstract
Background: Traditional drug delivery systems often face problems like low permeability, quick metabolism, poor targeting, and lower effectiveness. Lipid-based carriers, due to their unique chemical structure, ability to break down over time, and compatibility with the body, provide a helpful way to improve drug absorption, protect active molecules from breaking down, and reduce toxicity through controlled distribution and targeted delivery.
Aim: This article aims to give a clear overview of lipid-based systems for delivering drugs and nutraceuticals, focusing on their development, how they are characterized, their applications, and the challenges faced in industry.
Objectives: The objectives include discussing different types of lipid-based carriers, methods for characterization, the delivery of plant-derived bioactive using lipid-based systems, their applications in managing metabolic disorders, how targeted and controlled release works, and the role of artificial intelligence in improving formulations.
Conclusion: Lipid-based delivery systems are a flexible and effective way to improve the delivery of drugs and nutraceuticals by enhancing bioavailability, enabling targeted release, and reducing toxicity. Despite the progress made, issues related to stability, scalability, regulatory approval, and industrial manufacturing still exist. This underscores the need for better lipid engineering and AI-driven formulation methods for future advancements.
Keywords: Lipid-based carriers, Liposomes, Targeted drug delivery, Nanotechnology, Controlled drug release, Functional foods
Keywords:
Lipid-based carriers, Liposomes, Targeted drug delivery, Nanotechnology, Controlled drug release, Functional foodsDOI
https://doi.org/10.22270/jddt.v16i5.7720References
1. Porter CJ, Trevaskis NL, Charman WN. Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs. Nature reviews Drug discovery. 2007 Mar;6(3):231-48. https://doi.org/10.1038/nrd2197 PMid:17330072
2. Savjani KT, Gajjar AK, Savjani JK. Drug solubility: importance and enhancement techniques. International Scholarly Research Notices. 2012;2012(1):195727. https://doi.org/10.5402/2012/195727 PMid:22830056 PMCid:PMC3399483
3. Kalepu S, Nekkanti V. Insoluble drug delivery strategies: review of recent advances and business prospects. Acta Pharmaceutica Sinica B. 2015 Sep 1;5(5):442-53. https://doi.org/10.1016/j.apsb.2015.07.003 PMid:26579474 PMCid:PMC4629443
4. Pouton CW. Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system. European journal of pharmaceutical sciences. 2006 Nov 1;29(3-4):278-87. https://doi.org/10.1016/j.ejps.2006.04.016 PMid:16815001
5. Müller RH, Mäder K, Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery-a review of the state of the art. European journal of pharmaceutics and biopharmaceutics. 2000 Jul 3;50(1):161-77. https://doi.org/10.1016/S0939-6411(00)00087-4 PMid:10840199
6. Mehnert W, Mäder K. Solid lipid nanoparticles: production, characterization and applications. Advanced drug delivery reviews. 2012 Dec 1;64:83-101. https://doi.org/10.1016/j.addr.2012.09.021
7. Torchilin VP. Recent advances with liposomes as pharmaceutical carriers. Nature reviews Drug discovery. 2005 Feb 1;4(2):145-60. https://doi.org/10.1038/nrd1632 PMid:15688077 PMCid:PMC6702818
8. Nooshkam M, Varidi M. Maillard conjugate-based delivery systems for the encapsulation, protection, and controlled release of nutraceuticals and food bioactive ingredients: A review. Food Hydrocolloids. 2020 Mar 1;100:105389. https://doi.org/10.1016/j.foodhyd.2019.105389
9. Davoodi P, Feng F, Xu Q, Yan WC, Tong YW, Srinivasan MP, Sharma VK, Wang CH. Coaxial electrohydrodynamic atomization: Microparticles for drug delivery applications. Journal of Controlled Release. 2015 May 10;205:70-82. https://doi.org/10.1016/j.jconrel.2014.12.004 PMid:25483422
10. Al-Jipouri A, Almurisi SH, Al-Japairai K, Bakar LM, Doolaanea AA. Liposomes or extracellular vesicles: a comprehensive comparison of both lipid bilayer vesicles for pulmonary drug delivery. Polymers. 2023 Jan 7;15(2):318. https://doi.org/10.3390/polym15020318 PMid:36679199 PMCid:PMC9866119
11. Beloqui A, Solinís MÁ, Rodríguez-Gascón A, Almeida AJ, Préat V. Nanostructured lipid carriers: Promising drug delivery systems for future clinics. Nanomedicine: Nanotechnology, biology and medicine. 2016 Jan 1;12(1):143-61. https://doi.org/10.1016/j.nano.2015.09.004 PMid:26410277
12. Mehta S, Sangwan S, Dhawan V. Challenges in developing delivery systems of nutraceuticals and nanonutraceuticals. InHandbook of nutraceuticals: science, technology and engineering 2024 Feb 8 (pp. 1-25). Cham: Springer International Publishing. https://doi.org/10.1007/978-3-030-69677-1_23-1
13. Muthukrishnan L. Nanonutraceuticals-Challenges and novel nano-based carriers for effective delivery and enhanced bioavailability. Food and bioprocess technology. 2022 Oct;15(10):2155-84. https://doi.org/10.1007/s11947-022-02807-2
14. Kothapalli P, Vasanthan M. Lipid-based nanocarriers for enhanced delivery of plant-derived bioactive molecules: a comprehensive review. Therapeutic Delivery. 2024 Feb 1;15(2):135-55. https://doi.org/10.4155/tde-2023-0116 PMid:38214118
15. Patel P, Garala K, Singh S, Prajapati BG, Chittasupho C. Lipid-based nanoparticles in delivering bioactive compounds for improving therapeutic efficacy. Pharmaceuticals. 2024 Mar 1;17(3):329. https://doi.org/10.3390/ph17030329 PMid:38543115 PMCid:PMC10975431
16. Gorantla S, Wadhwa G, Jain S, Sankar S, Nuwal K, Mahmood A, Dubey SK, Taliyan R, Kesharwani P, Singhvi G. Recent advances in nanocarriers for nutrient delivery. Drug delivery and translational research. 2022 Oct;12(10):2359-84. https://doi.org/10.1007/s13346-021-01097-z PMid:34845678
17. Gandhi S, Shastri DH. Lipid-based nanoparticles as drug delivery system for modern therapeutics. Pharmaceutical Nanotechnology. 2024 Oct 11. https://doi.org/10.2174/0122117385275514231127062730 PMid:38185889
18. Xu L, Wang X, Liu Y, Yang G, Falconer RJ, Zhao CX. Lipid nanoparticles for drug delivery. Advanced NanoBiomed Research. 2022 Feb;2(2):2100109. https://doi.org/10.1002/anbr.202100109 PMCid:PMC11430251
19. Ganesan P, Narayanasamy D. Lipid nanoparticles: Different preparation techniques, characterization, hurdles, and strategies for the production of solid lipid nanoparticles and nanostructured lipid carriers for oral drug delivery. Sustainable Chemistry and Pharmacy. 2017 Dec 1;6:37-56. https://doi.org/10.1016/j.scp.2017.07.002
20. Makkar S, Sharma A, Rathore C, Joshi G, Rawat S. Recent Update on Applications of Nanostructured Lipid Carriers and Solid Lipid Nanocarriers in Drug Delivery Systems: A Narrative Review. Current Nanomedicine. 2025 Oct;15(5):503-22. https://doi.org/10.2174/0124681873299903240723112436
21. Ashfaq R, Rasul A, Asghar S, Kovács A, Berkó S, Budai-Szűcs M. Lipid nanoparticles: an effective tool to improve the bioavailability of nutraceuticals. International journal of molecular sciences. 2023 Oct 30;24(21):15764. https://doi.org/10.3390/ijms242115764 PMid:37958750 PMCid:PMC10648376
22. Musielak E, Feliczak-Guzik A, Nowak I. Synthesis and potential applications of lipid nanoparticles in medicine. Materials. 2022 Jan 17;15(2):682. https://doi.org/10.3390/ma15020682 PMid:35057398 PMCid:PMC8780297
23. Kumar S, Dilbaghi N, Saharan R, Bhanjana G. Nanotechnology as emerging tool for enhancing solubility of poorly water-soluble drugs. Bionanoscience. 2012 Dec;2(4):227-50. https://doi.org/10.1007/s12668-012-0060-7
24. Gangavarapu A, Tapia-Lopez LV, Sarkar B, Pena-Zacarias J, Badruddoza AZ, Nurunnabi M. Lipid nanoparticles for enhancing oral bioavailability. Nanoscale. 2024;16(39):18319-38. https://doi.org/10.1039/D4NR01487A PMid:39291697
25. Mehrdadi S. Lipid-based nanoparticles as oral drug delivery systems: Overcoming poor gastrointestinal absorption and enhancing bioavailability of peptide and protein therapeutics. Advanced Pharmaceutical Bulletin. 2023 Oct 14;14(1):48. https://doi.org/10.34172/apb.2024.016 PMCid:PMC10997935
26. Poovi G, Damodharan N. Lipid nanoparticles: A challenging approach for oral delivery of BCS Class-II drugs. Future Journal of Pharmaceutical Sciences. 2018 Dec 1;4(2):191-205. https://doi.org/10.1016/j.fjps.2018.04.001
27. Pandey S, Shaikh F, Gupta A, Tripathi P, Yadav JS. A recent update: solid lipid nanoparticles for effective drug delivery. Advanced pharmaceutical bulletin. 2021 May 16;12(1):17. https://doi.org/10.34172/apb.2022.007 PMCid:PMC9012924
28. Ranjbar, S., Emamjomeh, A., Sharifi, F., Zarepour, A., Aghaabbasi, K., Dehshahri, A., ... & Mohammadinejad, R. (2023). Lipid-based delivery systems for flavonoids and flavonolignans: Liposomes, nanoemulsions, and solid lipid nanoparticles. Pharmaceutics, 15(7), 1944. https://doi.org/10.3390/pharmaceutics15071944 PMid:37514130 PMCid:PMC10383758
29. Rehman M, Tahir N, Sohail MF, Qadri MU, Duarte SO, Brandão P, Esteves T, Javed I, Fonte P. Lipid-based nanoformulations for drug delivery: an ongoing perspective. Pharmaceutics. 2024 Oct 26;16(11):1376. https://doi.org/10.3390/pharmaceutics16111376 PMid:39598500 PMCid:PMC11597327
30. Paliwal R, Babu RJ, Palakurthi S. Nanomedicine scale-up technologies: feasibilities and challenges. Aaps Pharmscitech. 2014 Dec;15(6):1527-34. https://doi.org/10.1208/s12249-014-0177-9 PMid:25047256 PMCid:PMC4245446
31. Rajabi M, A. Mousa S. Lipid nanoparticles and their application in nanomedicine. Current pharmaceutical biotechnology. 2016 Jul 1;17(8):662-72. https://doi.org/10.2174/1389201017666160415155457 PMid:27087491
32. Das S, Chaudhury A. Recent advances in lipid nanoparticle formulations with solid matrix for oral drug delivery. Aaps Pharmscitech. 2011 Mar;12(1):62-76. https://doi.org/10.1208/s12249-010-9563-0 PMid:21174180 PMCid:PMC3066374
33. Wang S, Su R, Nie S, Sun M, Zhang J, Wu D, Moustaid-Moussa N. Application of nanotechnology in improving bioavailability and bioactivity of diet-derived phytochemicals. The Journal of nutritional biochemistry. 2014 Apr 1;25(4):363-76. https://doi.org/10.1016/j.jnutbio.2013.10.002 PMid:24406273 PMCid:PMC3959237
34. Mishra DK, Shandilya R, Mishra PK. Lipid based nanocarriers: a translational perspective. Nanomedicine: Nanotechnology, Biology and Medicine. 2018 Oct 1;14(7):2023-50. https://doi.org/10.1016/j.nano.2018.05.021 PMid:29944981
35. Waheed I, Ali A, Tabassum H, Khatoon N, Lai WF, Zhou X. Lipid-based nanoparticles as drug delivery carriers for cancer therapy. Frontiers in oncology. 2024 Apr 10;14:1296091. https://doi.org/10.3389/fonc.2024.1296091 PMid:38660132 PMCid:PMC11040677
36. Tekade RK, Maheshwari R, Tekade M, Chougule MB. Solid lipid nanoparticles for targeting and delivery of drugs and genes. InNanotechnology-based approaches for targeting and delivery of drugs and genes 2017 Jan 1 (pp. 256-286). Academic Press. https://doi.org/10.1016/B978-0-12-809717-5.00010-5
37. Godase SS, Kulkarni NS, Dhole SN. A comprehensive review on novel lipid-based nano drug delivery. Advanced Pharmaceutical Bulletin. 2023 Oct 14;14(1):34. https://doi.org/10.34172/apb.2024.012 PMid:38585464 PMCid:PMC10997939
38. Jacob S, Rao R, Gorain B, Boddu SH, Nair AB. Solid lipid nanoparticles and nanostructured lipid carriers for anticancer phytochemical delivery: advances, challenges, and future prospects. Pharmaceutics. 2025 Aug 21;17(8):1079. https://doi.org/10.3390/pharmaceutics17081079 PMid:40871098 PMCid:PMC12389418
39. Manocha S, Dhiman S, Grewal AS, Guarve K. Nanotechnology: An approach to overcome bioavailability challenges of nutraceuticals. Journal of Drug Delivery Science and Technology. 2022 Jun 1;72:103418. https://doi.org/10.1016/j.jddst.2022.103418
40. Sinha VR, Srivastava S, Goel H, Jindal V. Solid lipid nanoparticles (SLN’S)-trends and implications in drug targeting. International Journal of Advances in Pharmaceutical Sciences. 2010 Jul 1;1(3).
41. Harshita, Barkat MA, Das SS, Pottoo FH, Beg S, Rahman Z. Lipid-based nanosystem as intelligent carriers for versatile drug delivery applications. Current pharmaceutical design. 2020 Mar 1;26(11):1167-80. https://doi.org/10.2174/1381612826666200206094529 PMid:32026769
42. Shreya AB, Raut SY, Managuli RS, Udupa N, Mutalik S. Active targeting of drugs and bioactive molecules via oral administration by ligand-conjugated lipidic nanocarriers: recent advances. AAPS PharmSciTech. 2018 Dec 18;20(1):15. https://doi.org/10.1208/s12249-018-1262-2 PMid:30564942
43. Viegas C, Patrício AB, Prata JM, Nadhman A, Chintamaneni PK, Fonte P. Solid lipid nanoparticles vs. nanostructured lipid carriers: a comparative review. Pharmaceutics. 2023 May 25;15(6):1593. https://doi.org/10.3390/pharmaceutics15061593 PMid:37376042 PMCid:PMC10305282
44. Puri A, Loomis K, Smith B, Lee JH, Yavlovich A, Heldman E, Blumenthal R. Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinic. Critical Reviews™ in Therapeutic Drug Carrier Systems. 2009;26(6). https://doi.org/10.1615/CritRevTherDrugCarrierSyst.v26.i6.10 PMid:20402623 PMCid:PMC2885142
45. Mendoza-Muñoz N, Urbán-Morlán Z, Leyva-Gómez G, de la Luz Zambrano-Zaragoza M, Quintanar-Guerrero D. Solid lipid nanoparticles: an approach to improve oral drug delivery. Journal of Pharmacy & Pharmaceutical Sciences. 2021 Oct 13;24:509-32. https://doi.org/10.18433/jpps31788 PMid:34644523
46. Kumar R, Dkhar DS, Kumari R, Mahapatra S, Dubey VK, Chandra P. Lipid based nanocarriers: Production techniques, concepts, and commercialization aspect. Journal of Drug Delivery Science and Technology. 2022 Aug 1;74:103526. https://doi.org/10.1016/j.jddst.2022.103526
47. Fathi F, Machado TO, de AC Kodel H, Portugal I, Ferreira IO, Zielinska A, Oliveira MB, Souto EB. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for the delivery of bioactives sourced from plants: part I-composition and production methods. Expert opinion on drug delivery. 2024 Oct 2;21(10):1479-90. https://doi.org/10.1080/17425247.2024.2410951 PMid:39370828
48. Bukhari SI, Imam SS, Ahmad MZ, Vuddanda PR, Alshehri S, Mahdi WA, Ahmad J. Recent progress in lipid nanoparticles for cancer theranostics: opportunity and challenges. Pharmaceutics. 2021 Jun 7;13(6):840. https://doi.org/10.3390/pharmaceutics13060840 PMid:34200251 PMCid:PMC8226834
49. Shirodkar RK, Kumar L, Mutalik S, Lewis S. Solid lipid nanoparticles and nanostructured lipid carriers: emerging lipid based drug delivery systems. Pharmaceutical Chemistry Journal. 2019 Aug;53(5):440-53. https://doi.org/10.1007/s11094-019-02017-9
50. Harivardhan Reddy L, Murthy RS. Etoposide-loaded nanoparticles made from glyceride lipids: formulation, characterization, in vitro drug release, and stability evaluation. AAPs PharmSciTech. 2005 Jun;6(2):24. https://doi.org/10.1208/pt060224 PMid:16353973 PMCid:PMC2750527
51. Priya S, Desai VM, Singhvi G. Surface modification of lipid-based nanocarriers: a potential approach to enhance targeted drug delivery. ACS omega. 2022 Dec 20;8(1):74-86. https://doi.org/10.1021/acsomega.2c05976 PMid:36643539 PMCid:PMC9835629
52. Puri A, Mohite P, Munde S, Ade N, Ramole A, Pillai D, Nagare S, Mahadik S, Singh S. Unlocking the multifaceted potential of lipid-based dispersion as a drug carrier: Targeted applications and stability improvement strategies. Journal of Dispersion Science and Technology. 2025 Apr 22:1-33. https://doi.org/10.1080/01932691.2025.2496388
53. Yingchoncharoen P, Kalinowski DS, Richardson DR. Lipid-based drug delivery systems in cancer therapy: what is available and what is yet to come. Pharmacological reviews. 2016 Jul 1;68(3):701-87. https://doi.org/10.1124/pr.115.012070 PMid:27363439 PMCid:PMC4931871
54. Guillot AJ, Martínez-Navarrete M, Garrigues TM, Melero A. Skin drug delivery using lipid vesicles: A starting guideline for their development. Journal of Controlled Release. 2023 Mar 1;355:624-54. https://doi.org/10.1016/j.jconrel.2023.02.006 PMid:36775245
55. Boyd MA, Thavarajah W, Lucks JB, Kamat NP. Robust and tunable performance of a cell-free biosensor encapsulated in lipid vesicles. Science advances. 2023 Jan 4;9(1):eadd6605. https://doi.org/10.1126/sciadv.add6605 PMid:36598992 PMCid:PMC9812392
56. London E. Membrane structure-function insights from asymmetric lipid vesicles. Accounts of chemical research. 2019 Aug 6;52(8):2382-91. https://doi.org/10.1021/acs.accounts.9b00300 PMid:31386337 PMCid:PMC6954105
57. Pattnaik S, Swain K, Singh SP, Sirbaiya AK. Lipid vesicles: Potentials as drug delivery systems. InNanoengineered Biomaterials for Advanced Drug Delivery 2020 Jan 1 (pp. 163-180). Elsevier. https://doi.org/10.1016/B978-0-08-102985-5.00008-5
58. Manzoor M, Sharma P, Murtaza M, Jaiswal AK, Jaglan S. Fabrication, characterization, and interventions of protein, polysaccharide and lipid-based nanoemulsions in food and nutraceutical delivery applications: A review. International Journal of Biological Macromolecules. 2023 Jun 30;241:124485. https://doi.org/10.1016/j.ijbiomac.2023.124485 PMid:37076071
59. Aggarwal P, Sah SK, Ravichandiran V, Roy S, Kaity S. Liposomal Freight and Their Advanced Microstructure Characterization Techniques for Food and Nutraceutical Delivery. ACS Food Science & Technology. 2024 Aug 28;4(9):2013-35. https://doi.org/10.1021/acsfoodscitech.4c00493
60. Gupta A, Mittal V, Sharma A, Barak A, Arora D. Lipid-based drug delivery systems: A promising approach for overcoming bioavailability and solubility challenges in drug development. Current Nanomedicine. 2025 Apr;15(2):180-96. https://doi.org/10.2174/0124681873290199240424062503
61. Giordano A, Provenza AC, Reverchon G, Baldino L, Reverchon E. Lipid-based nanocarriers: bridging diagnosis and cancer therapy. Pharmaceutics. 2024 Sep 1;16(9):1158. https://doi.org/10.3390/pharmaceutics16091158 PMid:39339195 PMCid:PMC11434863
62. Khawas S, Mishra A, Vishwanaath R, Jaiswal P, Kumari A, Bhattacharjee S. Innovations in Nanocarrier technology for targeted therapeutics: A comprehensive review. REDVET-Revista electrónica de Veterinaria. 2024;25(1):2024. https://doi.org/10.69980/redvet.v25i1.780
63. MISHRA A, KUMARI A, BARAIK G, PALAK A. POLYMERIC NANOCARRIERS IN THERAPEUTIC DELIVERY: CURRENT TRENDS AND FUTURE HORIZONS. Int J Curr Pharm Sci. 2025 Jul. 15;17(4):38-44. Available from: https://journals.innovareacademics.in/index.php/ijcpr/article/view/55414. https://doi.org/10.22159/ijcpr.2025v17i4.7041
Published
Abstract Display: 0 
PDF Downloads: 0 PDF Downloads: 0 How to Cite
Issue
Section
Copyright (c) 2026 Anjali Mishra , Apoorva Kumari , Pranjal Kumar , Arya Kumari , Manas Ranjan Nayak , Rupam Vishwannaath
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.